Keywords: China, Biopharma industry development, Government support, Forecast

China’s biopharma industry a late starter, but making good progress – now valued at $8 billion; report

Article | 16 August 2010

The development of biologic drugs has gradually become the key focus of all drug companies worldwide, large or small, major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in